Literature DB >> 10829398

Validation of automated oscillometric sphygmomanometer (HDBPM) for arterial pressure measurement during haemodialysis.

S Cavalcanti1, G Marchesi, C Ghidini.   

Abstract

An HDBPM oscillometric sphygmomanometer used for the automatic measurement of arterial blood pressure is evaluated according to the ANSI/AAMI SP10-1992 standard. The accuracy of the HDBPM is ascertained by comparing it against the standard Riva-Rocci ascultatory method. Following the ascultatory method, two independent observers use the HDBPM devise to simultaneously measure the arterial blood pressure in 92 subjects of varying ages and having different blood pressures and arm sizes. High agreement is found when comparing the observers' pressure determinations (within 10 mmHg for 100% of observations). Correlation between the average of two ascultatory determinations and the HDBPM is high both for the systolic (r = 0.98) and diastolic (r = 0.94) pressures. The mean of the differences between the pressures measured by the observers and the HDBPM device are 0.2 mmHg (systolic) and -0.4 mmHg (diastolic). The percentages of readings within 10 mmHg between those taken by the observers and those taken by the HDBPM are 88% (systolic) and 97% (diastolic). These results largely satisfy current requirements.

Mesh:

Year:  2000        PMID: 10829398     DOI: 10.1007/bf02344696

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  7 in total

1.  The accuracy and clinical performance of a new compact ambulatory blood pressure monitoring device, the ES-H531.

Authors:  I Kuwajima; M Nishinaga; A Kanamaru
Journal:  Am J Hypertens       Date:  1998-11       Impact factor: 2.689

Review 2.  Hemodynamic instability during hemodialysis.

Authors:  W L Henrich
Journal:  Kidney Int       Date:  1986-10       Impact factor: 10.612

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  A comparison of the British Hypertension Society and Association for the Advancement of Medical Instrumentation protocols for validating blood pressure measuring devices: can the two be reconciled?

Authors:  E O'Brien; N Atkins
Journal:  J Hypertens       Date:  1994-09       Impact factor: 4.844

5.  Theory of the oscillometric maximum and the systolic and diastolic detection ratios.

Authors:  G Drzewiecki; R Hood; H Apple
Journal:  Ann Biomed Eng       Date:  1994 Jan-Feb       Impact factor: 3.934

6.  Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Postgraduate Education Committee.

Authors:  W M Kirkendall; M Feinleib; E D Freis; A L Mark
Journal:  Stroke       Date:  1981 Jul-Aug       Impact factor: 7.914

7.  The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems.

Authors:  E O'Brien; J Petrie; W Littler; M de Swiet; P L Padfield; K O'Malley; M Jamieson; D Altman; M Bland; N Atkins
Journal:  J Hypertens       Date:  1990-07       Impact factor: 4.844

  7 in total
  3 in total

1.  Blood pressure measurement in epidemiological investigations in teenagers.

Authors:  Y Coppieters; F Parent; L Berghmans; I Godin; A Levêque
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study.

Authors:  Rene' G VanDeVoorde; Gina M Barletta; Deepa H Chand; Ian G Dresner; Jerome Lane; Jeffrey Leiser; Jen-Jar Lin; Cynthia G Pan; Hiren Patel; Rudolph P Valentini; Mark M Mitsnefes
Journal:  Pediatr Nephrol       Date:  2006-11-07       Impact factor: 3.714

Review 3.  Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review.

Authors:  Noa Kallioinen; Andrew Hill; Mark S Horswill; Helen E Ward; Marcus O Watson
Journal:  J Hypertens       Date:  2017-03       Impact factor: 4.844

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.